SBI Life Insurance share: Shares of SBI Life Insurance gained significantly in Friday’s session by as much as 10 per cent to the day’s high price of Rs 1,763 per share on the BSE. The sharp spurt in the stock came even as the life insurer posted Q4 results below estimates.
Around 9:40 am, shares traded higher by 5 per cent or Rs 80.4 at Rs 1,689.25 apiece on the BSE.
SBI Life Q4FY25 earnings
Mumbai-headquartered SBI Life Insurance Company reported a net profit of Rs 814 crore for the quarter ended March 31, marking a decline of 0.4 per cent compared with the corresponding period a year ago. Its gross premium income, a measure of revenue for insurance businesses, came in at Rs 24,002 crore for the March quarter, marking a fall of 4.9 per cent on a year-on-year basis, according to a regulatory filing.
Net premium income during the review quarter is reported at Rs 23,861 crore, as against Rs 25,116.5 crore a year ago.
SBI Life’s solvency ratio, a key measure of an insurance company’s ability to meet its long-term financial obligations, remained unchanged at 1.96 per cent for the quarter ended March 31, 2025, as the corresponding period a year ago, it noted.
A solvency ratio reflects how much capital an insurer has relative to the risks that it bears over the long term. The higher this ratio, the stronger the financial position.
Both top-line and bottom-line fell short of analysts’ expectations.
According to Zee Business research, SBI Life Insurance was estimated to register a net profit of Rs 860 crore with gross premium income of Rs 25,340 crore for the final three months of FY25.
What brokerages suggest for SBI Life stock post Q4FY25 results?
The brokerages are largely positive to neutral on the stock with most raising target price for the stock. Citi gave the most bullish target for the stock at Rs 2,150- meaning significant possible upside of 34 per cent.
Following Citi, another brokerage Morgan Stanley keeping an ‘overweight’ rating has given a target of Rs 2,050.
SBI Life |
|||
Brokerages |
Rating |
New Target |
Old Target |
Jefferies |
Buy |
2000 |
1770 |
CLSA |
Hold |
1760 |
1670 |
Morgan Stanley |
Overweight |
2050 |
1910 |
Goldman Sachs |
Buy |
1860 |
1760 |
Bernstein |
Outperform |
2040 |
1900 |
Citi |
Buy |
2150 |
2100 |
Macquarie |
Neutral |
1435 |
|
Nomura |
Buy |
1800 |
|
3. SBI Life- below estimate
Gross premium income flat at 24001.5cr
Pat 813cr vs 810.8cr, up 6%
net premium income 23861cr vs 25116cr, down 5%
Anurag Dhole is a seasoned journalist and content writer with a passion for delivering timely, accurate, and engaging stories. With over 8 years of experience in digital media, she covers a wide range of topics—from breaking news and politics to business insights and cultural trends. Jane's writing style blends clarity with depth, aiming to inform and inspire readers in a fast-paced media landscape. When she’s not chasing stories, she’s likely reading investigative features or exploring local cafés for her next writing spot.